OBJECTIVES
To investigate the clinical characteristics, adverse drug reactions, and outcomes of the oldest old patients (aged ≥80 years) with tuberculosis (TB) treated with rifampicin, isoniazid, and pyrazinamide (RIP)-containing regimens.
DESIGN
A retrospective chart review study.
SETTING
A 1,200-bed tertiary teaching hospital in southwest Taiwan.
PARTICIPANTS
We conducted a retrospectiv...
